The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells

Liu,Guo  Dong; Xu,Chong; Feng,Le; Wang,Fang

doi:10.3892/ijmm.2015.2319

The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells

Authors:
- Guo Dong Liu
- Chong Xu
- Le Feng
- Fang Wang
View Affiliations

Affiliations: Department of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200072, P.R. China
Published online on: August 20, 2015 https://doi.org/10.3892/ijmm.2015.2319
Pages: 1019-1027
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It has recently been reported that O-linked β-N-acetyl glucosamine (O-GlcNAc) modification (a simple intracellular serine (Ser)/threonine (Thr)-linked monosaccharide) in human retinal microvascular endothelial cells (HRECs) is related to diabetic retinopathy (DR). During O-GlcNAcylation, O-GlcNAc is added to Ser and Thr residues. As the generation of reactive oxygen species (ROS) is one of the characteristics of advanced glycation end product (AGE) injury, and the most important key pathogenic factor of DR, in the present study, we aimed to investigate the association between O-GlcNAcylation and ROS generation in order to ascertain whether O-GlcNAcylation mitigates cellular injury through the generation of ROS. For this purpose, HRECs were divided into 4 groups as follows: HRECs treated with normal glucose (5 mM), HRECs treated with glyoxal (500 µM), glyoxal-treated HRECs also treated with 200 µM PUGNAc, and glyoxal-treated HRECs infected with O-GlcNAc transferase (OGT) siRNA. We detected increased O-GlcNAc levels and increased ROS production in the glyoxal-treated HRECs. The cellular redox status was determined by cellular ROS staining and by measuring the expression levels of the antioxidant genes, superoxide dismutase (SOD) and glutathione peroxidase (GPX). While the augmentation of O-GlcNAcylation following treatment with PUGNAc significantly attenuated the production of ROS (p<0.01) and increased the expression levels of SOD and GPX, the reduction of O-GlcNAcylation following infection with OGT siRNA, exacerbated the production of ROS (p<0.01) and decreased the expression of antioxidant genes. The effects of O-GlcNAcylation on the viability of HRECs were significant (p<0.01), particularly in the hydrogen peroxide (H2O2)-treated HRECs. Treatment with PUGNAc reduced glyoxal-induced cell apoptosis and transfection with OGT siRNA increased HREC apoptosis; these results were confirmed by flow cytometry and by the assessment of mitochondrial membrane potential. The augmentation of O-GlcNAcylation exerted cytoprotective effects on the HRECs by reducing the generation of ROS, increasing the expression of antioxidant genes, preventing the dissipation of mitochondrial membrane potential and preventing HREC apoptosis. Therefore, it can be concluded that O-GlcNAcylation plays a role in the early developmental process of DR.

View Figures

View References

1	Cheung N, Mitchell P and Wong TY: Diabetic retinopathy. Lancet. 376:124–136. 2010. View Article : Google Scholar : PubMed/NCBI
2	Shangari N, Bruce WR, Poon R and O'Brien PJ: Toxicity of glyoxals - role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans. 31:1390–1393. 2003. View Article : Google Scholar : PubMed/NCBI
3	Li SY, Sigmon VK, Babcock SA and Ren J: Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes. Life Sci. 80:1051–1056. 2007. View Article : Google Scholar
4	Al-Mesallamy HO, Hammad LN, El-Mamoun TA and Khalil BM: Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy. J Diabetes Complications. 25:168–174. 2011. View Article : Google Scholar
5	Mohamed IN, Soliman SA, Alhusban A, Matragoon S, Pillai BA, Elmarkaby AA and El-Remessy AB: Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats. Mol Vis. 18:1457–1466. 2012.PubMed/NCBI
6	Santos JM, Mohammad G, Zhong Q and Kowluru RA: Diabetic retinopathy, superoxide damage and antioxidants. Curr Pharm Biotechnol. 12:352–361. 2011. View Article : Google Scholar :
7	Scalbert P and Birlouez-Aragon I: Relationship between lens protein glycation and membrane structure in human cataract. Exp Eye Res. 56:335–340. 1993. View Article : Google Scholar : PubMed/NCBI
8	Buse MG: Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab. 290:E1–E8. 2006. View Article : Google Scholar
9	Younessi P and Yoonessi A: Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci. 36:154–166. 2011.PubMed/NCBI
10	Fernandes R, Hosoya K and Pereira P: Reactive oxygen species downregulate glucose transport system in retinal endothelial cells. Am J Physiol Cell Physiol. 300:C927–C936. 2011. View Article : Google Scholar : PubMed/NCBI
11	Hart GW: Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem. 66:315–335. 1997. View Article : Google Scholar : PubMed/NCBI
12	Gurel Z, Sieg KM, Shallow KD, Sorenson CM and Sheibani N: Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Mol Vis. 19:1047–1059. 2013.PubMed/NCBI
13	Xu C, Liu G, Liu X and Wang F: O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy. Int J Mol Med. 33:624–632. 2014.
14	Hart GW, Slawson C, Ramirez-Correa G and Lagerlof O: Cross talk between O-GlcNAcylation and phosphorylation: Roles in signaling, transcription, and chronic disease. Annu Rev Biochem. 80:825–858. 2011. View Article : Google Scholar : PubMed/NCBI
15	Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD and Hart GW: Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem. 279:30133–30142. 2004. View Article : Google Scholar : PubMed/NCBI
16	Ngoh GA, Facundo HT, Zafir A and Jones SP: O-GlcNAc signaling in the cardiovascular system. Circ Res. 107:171–185. 2010. View Article : Google Scholar : PubMed/NCBI
17	Zafir A, Readnower R, Long BW, McCracken J, Aird A, Alvarez A, Cummins TD, Li Q, Hill BG, Bhatnagar A, et al: Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells. 31:765–775. 2013. View Article : Google Scholar : PubMed/NCBI
18	Johnson B, Opimba M and Bernier J: Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Biochim Biophys Acta. 1840:191–198. 2014. View Article : Google Scholar
19	Nuñez G, Benedict MA, Hu Y and Inohara N: Caspases: the proteases of the apoptotic pathway. Oncogene. 17:3237–3245. 1998. View Article : Google Scholar
20	Kowluru RA and Chan PS: Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007:436032007. View Article : Google Scholar : PubMed/NCBI
21	Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 54:1615–1625. 2005. View Article : Google Scholar : PubMed/NCBI
22	Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI and Caldwell RW: Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets. 6:511–524. 2005. View Article : Google Scholar : PubMed/NCBI
23	Kanwar M, Chan PS, Kern TS and Kowluru RA: Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 48:3805–3811. 2007. View Article : Google Scholar : PubMed/NCBI
24	Tarr JM, Kaul K, Chopra M, Kohner EM and Chibber R: Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2013:3435602013. View Article : Google Scholar
25	Slawson C, Housley MP and Hart GW: O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem. 97:71–83. 2006. View Article : Google Scholar
26	Ma J and Hart GW: Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev Proteomics. 10:365–380. 2013. View Article : Google Scholar : PubMed/NCBI
27	Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field SJ and Evans RM: Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature. 451:964–969. 2008. View Article : Google Scholar : PubMed/NCBI
28	Hanover JA, Krause MW and Love DC: The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta. 1800:80–95. 2010. View Article : Google Scholar :
29	Sun J, Xu Y, Sun S, Sun Y and Wang X: Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species. Mol Cell Biochem. 343:27–35. 2010. View Article : Google Scholar : PubMed/NCBI
30	Al-Shabrawey M and Smith S: Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers. EPMA J. 1:56–72. 2010. View Article : Google Scholar : PubMed/NCBI
31	Kennedy A and Frank RN: The influence of glucose concentration and hypoxia on VEGF secretion by cultured retinal cells. Curr Eye Res. 36:168–177. 2011. View Article : Google Scholar
32	Loukovaara S, Koivunen P, Inglés M, Escobar J, Vento M and Andersson S: Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol. 92:323–327. 2014. View Article : Google Scholar
33	Izuta H, Matsunaga N, Shimazawa M, Sugiyama T, Ikeda T and Hara H: Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body. Mol Vis. 16:130–136. 2010.PubMed/NCBI
34	Moley KH and Mueckler MM: Glucose transport and apoptosis. Apoptosis. 5:99–105. 2000. View Article : Google Scholar
35	Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J and Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA. 97:12222–12226. 2000. View Article : Google Scholar : PubMed/NCBI
36	Pang Y, Hunton DL, Bounelis P and Marchase RB: Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes. 51:3461–3467. 2002. View Article : Google Scholar : PubMed/NCBI
37	Zhao L, Yan X, Shi J, Ren F, Liu L, Sun S and Shan B: Ethanol extract of Forsythia suspensa root induces apoptosis of esophageal carcinoma cells via the mitochondrial apoptotic pathway. Mol Med Rep. 11:871–880. 2015.
38	Watanabe J, Nakamachi T, Ohtaki H, Naganuma A, Shioda S and Nakajo S: Low dose of methylmercury (MeHg) exposure induces caspase mediated-apoptosis in cultured neural progenitor cells. J Toxicol Sci. 38:931–935. 2013. View Article : Google Scholar : PubMed/NCBI
39	Housley MP, Udeshi ND, Rodgers JT, Shabanowitz J, Puigserver P, Hunt DF and Hart GW: A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem. 284:5148–5157. 2009. View Article : Google Scholar :
40	O'Rourke B: Mitochondrial ion channels. Annu Rev Physiol. 69:19–49. 2007. View Article : Google Scholar
41	Feissner RF, Skalska J, Gaum WE and Sheu SS: Crosstalk signaling between mitochondrial Ca²⁺ and ROS. Front Biosci (Landmark Ed). 14:1197–1218. 2009. View Article : Google Scholar
42	Nagy T, Champattanachai V, Marchase RB and Chatham JC: Glucosamine inhibits angiotensin II-induced cytoplasmic Ca²⁺ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. Am J Physiol Cell Physiol. 290:C57–C65. 2006. View Article : Google Scholar
43	Ngoh GA, Watson LJ, Facundo HT and Jones SP: Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids. 40:895–911. 2011. View Article : Google Scholar :